Formulation parameters of crystalline nanosuspensions on spray drying processing: A DoE approach

International Journal of Pharmaceutics

Volumn 464, Issue 1-2, 2014, Pages 34-45

  Kumar, Sumit ^a   Xu, Xiaoming ^a   Gokhale, Rajeev ^b   Burgess, Diane J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b ABBVIE INC   (United States)

Author keywords

DoE; Nanocrystalline; Nanosuspension; Re dispersion; Spray drying

Indexed keywords

INDOMETACIN; NANOCRYSTAL; NAPROXEN; METHAMPHETAMINE; NANOCRYSTALLINE; NANOPARTICLE; NANOSUSPENSION;

ARTICLE; DOWNSTREAM PROCESSING; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; GLASS TRANSITION TEMPERATURE; MICROCRYSTALLINE SUSPENSION; MOISTURE; PARAMETERS; PARTICLE SIZE; POWDER; PRIORITY JOURNAL; SPRAY DRYING; X RAY POWDER DIFFRACTION; CHEMISTRY; MEDICINAL CHEMISTRY; METHODOLOGY; RE-DISPERSION; SUSPENSION; X RAY DIFFRACTION;

DOE; NANOCRYSTALLINE; NANOSUSPENSION; RE-DISPERSION; SPRAY DRYING;

CHEMISTRY, PHARMACEUTICAL; NANOPARTICLES; PARTICLE SIZE; SUSPENSIONS; X-RAY DIFFRACTION;

EID: 84893946528     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.01.013     Document Type: Article

References (25)

1. A.M. Cerdeira, M. Mazzotti, and B. Gander Formulation and drying of miconazole and itraconazole nanosuspensions Int. J. Pharm. 443 2013 209 220
2. M.V. Chaubal, and C. Popescu Conversion of nanosuspensions into dry powders by spray drying: a case study Pharm. Res. 25 2008 2302 2308
3. P.J. Flory Principles of Polymer Chemistry 1953 Cornell University Press Ithaca
4. P. Gribbon, and A. Sewing High-throughput drug discovery: what can we expect from HTS? Drug Discov. Today 10 2005 17 22 (Pubitemid 40164815)
5. J.E. Kipp The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs Int. J. Pharm. 284 2004 109 122 (Pubitemid 39349144)
6. S. Kumar, and D.J. Burgess Nanosuspension: Controlled release science and technology J. Wright, D.J. Burgess, Long Acting Injections and Implants 2012 CRS Press, Springer 239 262 (Chapter 13)
7. J. Lee Drug nano- and microparticles processed into solid dosage forms: physical properties J. Pharm. Sci. 92 2003 2057 2068 (Pubitemid 37175635)
8. C.A. Lipinski Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 44 2000 235 249 (Pubitemid 32239479)
9. C.A. Lipinski Poor aqueous solubility - an industry wide problem in drug discovery Am. Pharm. Rev. 5 2002 82 85
10. C.A. Lipinski et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 46 2001 3 26 (Pubitemid 33653411)
11. Liversidge, E., Wei, L., 2003. Stabilization of chemical compounds using nanoparticulate formulations. US 2001; 952032 20010914. CAN 138:243327, US 20030504042 A1.
12. L. Mandelkern Crystallization of Polymers 1964 New York McGraw-Hill
13. P.J. Marsac et al. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility Pharm. Res. 22 2006 2417 2426 (Pubitemid 44511522)
14. P.J. Marsac et al. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters Pharm. Res. 26 2009 139 151
15. E.M. Merisko-Liversidge, and G.G. Liversidge Drug nanoparticles formulating poorly water-soluble compounds Toxicol. Pathol. 36 2008 43 48
16. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2003 113 120 (Pubitemid 36184748)
17. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanocrystal drug particles: resolving pharmaceutical formulation issues associated with poorly water-soluble compounds Abstr. Papers Am. Chem. Soc. 226 2003 U528
18. R. Muller, C. Jacobs, and O. Kayser DissoCubes: A Novel Formulation for Poorly Soluble and Poorly Bioavailable Drugs 1st ed. 2003 Marcel Dekker New York
19. A. Noyes, and W. Whitney The rate of solution of solid substance in their own solutions J. Am. Chem. Soc. 19 1897 930 934
20. A. Simonelli, S. Mehta, and W. Higuchi Inhibition of sulphathaizole crystal growth by polyvinylpyrrolidone J. Pharm. Sci. 59 1970 633 638
21. F. Troester Chremophore-free aqueous paclitaxel nanosuspension production and chemical stability Controlled Release Society 31st Annual Meeting Honolulu, HI 2004
22. B. Van Eerdenbrugh et al. Drying of crystalline drug nanosuspensions - the importance of surface hydrophobicity on dissolution behavior upon redispersion Eur. J. Pharm. Sci. 35 2008 127 135
23. B. Van Eerdenbrugh et al. Alternative matrix formers for nanosuspension solidification: dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion Eur. J. Pharm. Sci. 35 2008 344 353
24. B. Van Eerdenbrugh et al. Microcrystalline cellulose: a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole Eur. J. Pharm. Biopharm. 70 2008 590 596
25. S. Verma, R. Gokhale, and D.J. Burgess A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions Int. J. Pharm. 380 2009 216 222